D. Campos

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.

D. Chan, I. Thompson, A. Partin, 2005, Clinical chemistry.

Molecular determinants of differential sensitivity to docetaxel and paclitaxel in human pediatric cancer models.

A. Tolcher, G. Mangold, D. Campos, 2006, Anticancer research.

Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers

R. Steffen, D. Campos, E. Izbicka, 2009, Cancer Chemotherapy and Pharmacology.

Biomarkers of anticancer activity of R115777 (Tipifarnib, Zarnestra) in human breast cancer models in vitro.

A. Patnaik, D. Campos, E. Izbicka, 2005, Anticancer research.

Regulation of tumor signaling pathways by AZD3409 in vitro.

D. Campos, E. Izbicka, T. Stephens, 2006, Anticancer research.

Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women.

J. Michalek, D. Campos, E. Izbicka, 2012, Cancer genomics & proteomics.

Syntra-5 downregulates inflammatory signaling in obese type 2 diabetes murine model in vivo

J. Michalek, D. Campos, E. Izbicka, 2011 .

Biomarkers for Sensitivity to Docetaxel and Paclitaxel in Human Tumor Cell Lines In Vitro.

A. Tolcher, D. Campos, E. Izbicka, 2005, Cancer genomics & proteomics.